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Objective: To estimate the efficiency of a cough assistance de-
vice, the Cough Aid, in patients with weak respiratory mus-
cles with bulbar palsy and/or tracheostomy. The Cough Aid 
is a device that has been developed to substitute for glottis 
function.
Design: Before-after trial.
Subjects/patients: A total of 74 patients with bulbar palsy 
and/or tracheostomy, as well as respiratory muscle weak-
ness, were recruited.
Methods: Forced vital capacity, unassisted cough peak flow, 
lung insufflation capacity, and assisted cough peak flow were 
measured via tracheostomy or oronasal interface. Lung in-
sufflation capacity and assisted cough peak flow were mea-
sured using the Cough Aid.
Results and conclusion: In all 74 subjects, lung insufflation 
capacities measured with the device were significantly high-
er than forced vital capacities (p < 0.01). Assisted cough peak 
flows measured using the device were also significantly high-
er than unassisted cough peak flows (p < 0.01). The Cough 
Aid is effective in helping to increase cough flow and assist-
ing in the air stacking exercise by substituting the function 
of the glottis in patients who have glottis dysfunction or a 
tracheostomy tube.
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INTRoduCTIoN
An effective cough is an indispensable host defence mechanism 
for clearing the airways (1). Ineffective coughing leads to 
pulmonary complications, such as pneumonia and atelectasis 
(2, 3). The phases of cough are classified as: (i) inspiratory, 
(ii) compressive, and (iii) expiratory (1, 4, 5). The inhalation 
of a large volume of air characterizes the inspiratory phase. In 
the compressive phase the glottis is closed and intra-thoracic 
pressure is increased. In the expiratory phase the glottis is 
opened and the expiratory muscles contract. A cough is inef-
fective when only one of these phases fails. 
A manually assisted cough helped by abdominal thrust 
improves cough flow dynamics and can help patients whose 
expiratory muscles are weak (6, 7). For patients who have 
weak inspiratory muscles, receiving maximal insufflations via 
a manual resuscitation bag or by air-stacking before a manual 
thrust can create an effective cough (8, 9). 
When glottis closure is incomplete or tracheostomized in 
patients with expiratory muscle weakness, an increase in the 
intra-thoracic pressure will be ineffective. Thus, the efficient 
expiratory flows required for coughing cannot be obtained. For 
some patients who have sufficient expiratory muscle strength 
and can generate huffing, glottis closure appears not to be criti-
cal for the development of an effective cough. However, glottis 
closure is an important contributory factor, and it is difficult to 
augment a cough by assisted coughing methods in patients with 
weakened expiratory muscle activation and impaired glottis func-
tion (10–12). Therefore, a device that supports impaired bulbar 
muscle function will help many patients who cannot cough due 
to bulbar muscle weakness or tracheostomy. External glottis 
closure is needed to induce maximum passive lung insufflation 
in patients with glottis dysfunction and/or tracheostomy. Passive 
lung insufflation can be achieved by using a manual resuscitator 
connected to a spirometer, with the expiratory port of the spirom-
eter occluded during insufflation. Using this method sufficient 
lung insufflation capacity (LIC) can be obtained (13). 
We have previously developed and tested such a device 
as a prototype and have shown the effectiveness of external 
control of exhalation in patients with glottis dysfunction and/
or tracheostomy (14). 
A new model for external control of exhalation has now been 
developed that is simpler and easier to use in the clinical situ-
ation. The aim of this study is to evaluate how the new device 
affects cough augmentation in patients with glottis dysfunction 
and/or tracheostomy. 
METHodS
“Cough Aid” design
The Cough Aid comprises two parts: the connection part and the 
control part, as follows.
CoUgh ASSISTANCE DEVICE For PATIENTS wITh gLoTTIS 
dySFuNCTIoN ANd/oR TRACHEoSToMy
Won Ah Choi, MD1, Jung Hyun Park, MD, PhD1, Dong Hyun Kim, MD2 
and Seong-Woong Kang, MD, PhD1
From the 1Department of Rehabilitation Medicine and Rehabilitation Institute of Muscular Disease, Yonsei University 
College of Medicine and 2Department of Rehabilitation Medicine, Kangdong Sacred Hospital, Hallym University  
College of Medicine, Seoul, Korea
352 W. A. Choi et al.
The connection part is a T-shape plastic tube with 3 main air path-
ways: a patient connection port, an insufflation port, and an exsuffla-
tion port (Fig. 1A). The patient connection port is connected to the 
patients’ airway via an oronasal mask or tracheostomy tube. A manual 
resuscitation bag can be connected to the cylindrical-shaped insuffla-
tion port located in the centre at a right angle to the device, and the 
airstream from the resuscitation bag passes through a one-way valve, 
which cannot leak (Fig. 1B). The exsufflation port is the air pathway 
connected to the control part. The control part, the essential part of 
the Cough Aid, enables the patient artificially to modulate the func-
tion of glottic opening and closing (Fig. 1A). When the pushing bar 
is not pressed, it blocks the exhaust holes, so that the air cannot pass 
through the control part. when the pushing bar is pressed, the airflow 
can pass through the control part via opened exhaust holes, which are 
the only route by which air can exit from the device. 
When the pushing bar is not pressed, additional air can be instilled 
to the patient’s lungs by using a manual resuscitation bag just after the 
patient’s voluntary maximal inhalation. The Cough Aid was designed 
to allow no leakage of insufflated air and to hold enough air to increase 
the intra-thoracic pressure sufficiently for a cough-like exhalation (Fig. 
1C). When the pushing bar is pressed the control part acts exactly like 
the glottis; exhaled air passes freely from the connection part to the 
outside of the device through the exhaust holes of the control part. 
Thus, patients are able to exhale with a fast airflow, similar to normal 
cough augmentation with an intact glottis function.
This trial was approved by the Institutional Review Board of the 
Kangnam Severance Hospital, yonsei university College of Medicine 
in Seoul, South Korea (3-2008-0119). 
Patients
A total of 74 patients with bulbar palsy and/or tracheostomy, as well 
as inspiratory and expiratory muscle weakness, were recruited in this 
study. The patients, who had dysarthria and/or dysphagia, were consid-
ered to have bulbar dysfunction, and they could not hold inhaled air to 
measure cough peak flow (CPF) after air stacking with a resuscitation 
bag in the preliminary study. Exclusion criteria were: lung disease, or 
inability to co-operate due to mental or physical problems. The study 
was approved by the institutional review board, and informed consent 
was obtained from all study subjects.
Clinical evaluation
Forced vital capacity (FVC) and lung insufflation capacity (LIC). 
The FVC and LIC were measured to evaluate briefly the pulmonary 
function status of the patients. The FVC was measured in the sitting 
position using a commercial flow analyser test system (Certifier® FA, 
TSI Inc., Shoreview, MN, uSA) via a tracheostomy tube or oronasal 
interface. This process was repeated at least 3 times; the highest value 
being selected as the FVC. The LIC by air stacking was achieved when 
the patient took a deep breath, held it, and then a maximum volume 
was delivered through the Cough Aid while the pushing bar was not 
pressed. The patient then exhaled the maximally held volume of air 
into a commercial flow analyser test system (Certifier® FA, TSI Inc., 
Shoreview, MN, uSA) through the Cough Aid with the pushing bar 
pressed. The maximum value of 3 or more attempts was recorded.
Unassisted CPF (UCFP) and assisted CPF (ACPF) using the Cough 
Aid. The UCPF was measured using a commercial flow analyser test 
system (Certifier® FA) by having the subject cough as forcefully as 
possible through the Cough Aid at the same time as the pushing bar 
was pressed for air to pass through the Cough Aid. To measure the 
ACPF, maximal air stacking was performed through the Cough Aid 
while the pushing bar was not pressed. The patient then attempted to 
cough when the pushing bar was pressed and manual abdominal thrust 
was applied. For tracheostomized patients, the CPFs under different 
conditions were measured through a tube with the cuff inflated. The 
maximum value of 3 or more attempts was recorded.
Data analysis
The paired t-test was used to determine whether the difference be-
tween the UCPF and ACPF was significant. If two parameters showed 
statistical significance, it was assumed that the Cough Aid was effec-
tive in cough augmentation of the patients with bulbar palsy and/or 
tracheostomy. data were analysed using SPSS 15.0. A p-value < 0.05 
was considered statistically significant.
rESULTS
A total of 74 subjects who met the criteria were evaluated. 
Twenty-seven of the subjects had bulbar palsy and were 
diagnosed as amyotrophic lateral sclerosis (ALS). The para-
meters were measured via the oronasal interface in this group 
(Group 1). Forty-seven subjects had tracheostomy tubes, so 
the parameters had to be evaluated through the tracheostomy 
tubes. In this group (group 2), 15 were ALS patients and 24 
had cervical spinal cord injuries. The remaining 8 patients 
had duchenne muscular dystrophy, Guillain-Barré syndrome, 
multiple sclerosis, and stroke, etc. (Table I).
In all the 74 subjects, the LICs (mean 1536.9 ml, standard 
deviation (SD) 714.9 ml) measured by a commercial flow 
analyser test system  (Certifier® FA) using the Cough Aid were 
significantly higher than FVCs (mean 904.8 ml, SD 536.5 ml, 
p < 0.01). The same patterns were observed in Group 1 and 2 
(p < 0.01) (Table II). 
The ACPFs (mean 133.5 l/min, Sd 72.6 l/min) measured 
using the Cough Aid were significantly higher than the UCPFs 
Fig. 1. “Cough Aid” device. When performing air-stacking exercise and cough-assisting method, previously inhaled air does not leak though the valve; 
when the patient exhales or coughs, the pushing bar is pressed at the same time and the exhaled air is exhausted through the concave portion of the 
pushing bar. (A) disassembled view. (B) Complete view showing inner parts. (C) The device connected to a manual resuscitation bag.
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(mean 73.9 l/min, Sd 49.7 l/min) in a total of 74 subjects 
(p < 0.01). Also, in groups 1 and 2, the ACPFs were signifi-
cantly higher than the uCPF (p < 0.01) (Table II).
dISCuSSIoN
To produce an effective cough, all phases of cough augmenta-
tion are important: inspiration, expiration, and compression. 
Impaired inspiratory function can be substituted by a manual 
insufflation bag to supply an additional volume of air (11), and 
weak expiratory muscles can be assisted by an abdominal thrust 
(15). The combination of both air stacking and abdominal thrust 
is better than either alone (9). However, in the case of a patient 
with a failed glottis and/or a tracheostomy, very few methods 
can help. The failure of the glottis causes problems in the com-
pressive phase, thus it is impossible to hold the pre-cough vol-
ume, and an effective cough flow cannot be established. Even 
though the air has been supplied, it leaks out from the lungs. 
Tracheostomized patients also cannot produce an effective 
cough. These patients have difficulty initiating the compres-
sive phase, and cough flow cannot be accrued sufficiently by 
using the several cough-assisted methods (16, 17). Therefore, 
passive lung insufflation by LIC could be significantly greater 
than air stacking in patients with bulbar palsy (13).
We developed the simple Cough Aid device, which pro-
vided the benefit of sufficient LIC, and clinically proved 
its usefulness. This device could be applied to patients with 
glottis dysfunction and/or tracheostomy. In this study, LIC 
and ACPF were greater than FVC and CPF, which meant that 
the Cough Aid was effective in holding the pre-cough volume 
and cough augmentation in patients with bulbar palsy and/or 
tracheostomy, because the main function of the device was to 
assist the compressive phase of the cough. 
We assume that the Cough Aid would be particularly useful 
in ALS patients with bulbar palsy who have yet to be trache-
ostomized. In these patients, it is difficult to assist a cough by 
both air stacking and abdominal thrust, because they depend 
only on bulbar-innervated muscle function (9). Therefore, if 
we can substitute the glottis function of these patients, it is 
possible to augment enough coughing for airway secretion by 
manually assisted coughing. For these reasons, the Cough Aid 
is a suitable device, and we conclude that the use of this device 
could help these patients to ease respiratory secretion care, 
decrease pulmonary complications, and reduce the length of 
time for which they need to be tracheostomized. In this study, 
the device was more effective in increasing ACPF in the ALS 
group without tracheostomy than in the tracheostomy group.
In some patients with neuromuscular diseases, respiratory 
function worsens as muscle weakness progresses. Pulmonary 
compliance is lost because the ability to expand the lungs to 
the predicted inspiratory capacity is lost as the vital capacity 
decreases (18). To prevent chest-wall contractures and lung 
restriction, regular range-of-motion is required, which can 
be achieved only by providing deep insufflations, air stack-
ing, or nocturnal non-invasive ventilation (19, 20). However, 
these methods are not available in patients with bulbar palsy, 
because it is impossible for them to hold enough air to prevent 
or eliminate atelectasis. The Cough Aid has an insufflation port 
to connect a manual insufflation bag, which can be useful to 
maintain lung range-of-motion and pulmonary compliance 
when combined with LIC. To maintain pulmonary compli-
ance, lung growth, and the chest-wall, mobility is an important 
management principle in patients with restrictive pulmonary 
impairment. The Cough Aid is cheap, light-weight, simple, 
easy to operate, and does not require electricity, so it can easily 
be used for airway clearance in patients with bulbar palsy. We 
have shown that LIC with the Cough Aid was greater than VC 
without the device. Further studies of pulmonary compliance 
with the device are required. 
The limitations of this study include the small number of 
patients and the heterogeneity of the patients. We divided the 
subjects into two groups, according to whether they had a 
tracheostomy. However, the tracheostomy group (Group 2) 
included patients with different diagnoses, and some patients 
Table I. Subjects’ characteristics 
Total 
(n = 74)
Group 1 
(n = 27)
Group 2 
(n = 47)
Sex, n
Men 54 18 36
Women 20 9 11
Age, years, mean (Sd) 52.9 (12.5) 56.0 (11.0) 51.1 (13.1)
Height, cm, mean (Sd) 166.4 (10.1) 163.6 (12.3) 168.0 (8.4)
Weight, kg, mean (Sd) 57.3 (11.8) 57.3 (14.3) 57.3 (10.3)
diagnosis, n
ALS 42 27 15
Cervical SCI 24 24 
dMd 1 1 
GBS 1 1 
MS 1 1 
Stroke 2 2 
MG 2 2 
SMA type 3 1 1
group 1: patients with bulbar palsy all diagnosed as ALS without 
tracheostomy. Group 2: patients with tracheostomy.
ALS: amyotrophic lateral sclerosis; SCI: spinal cord injury; DMD: 
duchenne muscular dystrophy; GBS: Guillain-Barré syndrome; MS: 
multiple sclerosis; MG: myasthenia gravis; SMA: spinal muscular atrophy; 
Sd: standard deviation.
Table II. Results of pulmonary function test for the subjects
Total (n = 74)
Mean (Sd)
Group 1 (n = 27)
Mean (Sd)
Group 2 (n = 47)
Mean (Sd)
FVC, ml 904.8 (536.5)* 1,060.2 (547.0)* 815.5 (515.1)*
LIC, ml 1,536.9 (714.9)* 1,599.5 (907.4)* 1,501.0 (584.8)*
uCPF, l/min 73.9 (49.7)* 104.7 (51.2)** 56.1 (39.5)*
ACPF, l/min 133.5 (72.6)* 174.7 (89.3)** 109.8 (47.8)*
*Paired t-test, p < 0.01, **Paired t-test, p = 0.01. 
group 1: patients with bulbar palsy all diagnosed as ALS without 
tracheostomy. The parameters were evaluated via oronasal interface. 
Group 2: patients with tracheostomy.
FVC: forced vital capacity; LIC: lung insufflation capacity; UCPF: 
unassisted cough peak flow; ACPF: assisted cough peak flow; SD: 
standard deviation.
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might have had intact glottis function, whereas others may 
not. Further analysis of the effects of various glottis condi-
tions is warranted. 
In conclusion, the Cough Aid is an effective device to in-
crease cough flow and assist with air-stacking exercises by 
substituting the function of the glottis in patients with glottis 
dysfunction and/or tracheostomy. The device is small, light-
weight, and easy to handle; thus it can be used in patients 
who cannot cough effectively with the help of existing cough-
assistance methods.
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